NCT02195687

BOTOX® in the Treatment of Crow's Feet Lines in China

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 417 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) compared with placebo in patients with moderate to severe crow's feet lines (lateral canthal lines).

Conditions

• Lateral Canthal Lines
• Crow's Feet Lines

Interventions

Type	Name	Description
BIOLOGICAL	botulinum toxin Type A	botulinum toxin Type A (BOTOX®) injected into bilateral crow's feet line areas.
DRUG	Normal Saline	Normal Saline (placebo) injected into bilateral Crow's Feet Line areas.

Timeline

• Start date: 2014-09-01
• Primary completion: 2015-02-01
• Completion: 2015-06-01
• First posted: 2014-07-21
• Last updated: 2016-03-14
• Results posted: 2016-03-14

Locations

1 site across 1 country: China